ACR appropriateness criteria® management of locoregionally advanced squamous cell carcinoma of the vulva

American Journal of Clinical Oncology: Cancer Clinical Trials

Volumn 36, Issue 4, 2013, Pages 415-422

  Kidd, Elizabeth ^a   Moore, David ^b   Varia, Mahesh A ^c   Gaffney, David K ^d   Elshaikh, Mohamed A ^e   Erickson, Beth ^f   Jhingran, Anuja ^g   Lee, Larissa J ^h   Mayr, Nina A ⁱ   Puthawala, Ajmel A ^j   Rao, Gautam G ^k   Small, William ^l   Wahl, Andrew O ^m   Wolfson, Aaron H ⁿ   Yashar, Catheryn M ^o   Yuh, William ^p   Cardenes, Higinia Rosa ^q  

^a STANFORD CANCER INSTITUTE   (United States)

^b INDIANA UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c UNIVERSITY OF NORTH CAROLINA SCHOOL OF MEDICINE   (United States)

^d UNIVERSITY OF UTAH HEALTH SCIENCES CENTER   (United States)

^e HENRY FORD HEALTH SYSTEM   (United States)

^f MEDICAL COLLEGE OF WISCONSIN   (United States)

^g UNIVERSITY OF TEXAS   (United States)

^h BRIGHAM AND WOMEN S HOSPITAL   (United States)

ⁱ OHIO STATE UNIVERSITY   (United States)

^j LONG BEACH MEMORIAL MEDICAL CENTER   (United States)

^k UNIVERSITY OF MARYLAND SCHOOL OF MEDICINE   (United States)

^l NORTHWESTERN UNIVERSITY   (United States)

^m UNIVERSITY OF NEBRASKA MEDICAL CENTER   (United States)

ⁿ UNIVERSITY OF MIAMI   (United States)

^o UNIVERSITY OF CALIFORNIA   (United States)

^p OHIO STATE UNIVERSITY   (United States)

^q INDIANA UNIVERSITY MEDICAL CENTER   (United States)

more..

Author keywords

Appropriateness Criteria; neoadjuvant chemoradiotherapy; vulvar cancer

Indexed keywords

BLEOMYCIN; CISPLATIN; FLUOROURACIL; LOMUSTINE; METHOTREXATE; MITOMYCIN; VINCRISTINE;

ADJUVANT CHEMORADIOTHERAPY; BRACHYTHERAPY; CANCER RECURRENCE; COLOSTOMY; DISTANT METASTASIS; EXTERNAL BEAM RADIOTHERAPY; FINE NEEDLE ASPIRATION BIOPSY; HUMAN; INGUINAL LYMPH NODE; INTENSITY MODULATED RADIATION THERAPY; LOCOREGIONALLY ADVANCED VULVA CANCER; LYMPH NODE DISSECTION; LYMPH NODE METASTASIS; MEDICAL LITERATURE; NUCLEAR MAGNETIC RESONANCE IMAGING; PELVIS EXENTERATION; PHASE 2 CLINICAL TRIAL (TOPIC); POSITRON EMISSION TOMOGRAPHY; PRACTICE GUIDELINE; PREDICTIVE VALUE; PREOPERATIVE RADIOTHERAPY; RADIATION FIELD; REVIEW; SENTINEL LYMPH NODE BIOPSY; SKIN MANIFESTATION; SQUAMOUS CELL CARCINOMA; SURVIVAL RATE; TREATMENT PLANNING; VULVA CANCER; VULVECTOMY; WOUND COMPLICATION;

EID: 84880966946     PISSN: 02773732     EISSN: 1537453X     Source Type: Journal    
DOI: 10.1097/COC.0b013e318295af1d     Document Type: Review

References (65)

1. Siegel R, Naishadham D, Jemal A. Cancer statistics, 2012. CA Cancer J Clin. 2012;62:10-29.
2. Howlader N, Noone AM, Krapcho M, et al. SEER Cancer Statistics Review, 1975-2008, National Cancer Institute. Bethesda, MD, 2012. Available at: http://seer.cancer.gov/statfacts/html/vulva.html. Accessed June 20, 2012.
3. Hacker NF. Revised FIGO staging for carcinoma of the vulva. Int J Gynaecol Obstet. 2009;105:105-106.
4. Pecorelli S, Zigliani L, Odicino F. Revised FIGO staging for carcinoma of the cervix. Int J Gynaecol Obstet. 2009;105:107-108.
5. Piura B, Rabinovich A, Cohen Y, et al. Squamous cell carcinoma of the vulva in the south of Israel: a study of 50 cases. J Surg Oncol. 1998;67:174-181.
6. Hall TB, Barton DP, Trott PA, et al. The role of ultrasound-guided cytology of groin lymph nodes in the management of squamous cell carcinoma of the vulva: 5-year experience in 44 patients. Clin Radiol. 2003;58:367-371.
7. Moskovic EC, Shepherd JH, Barton DP, et al. The role of high resolution ultrasound with guided cytology of groin lymph nodes in the management of squamous cell carcinoma of the vulva: a pilot study. Br J Obstet Gynaecol. 1999;106:863-867.
8. Grigsby PW, Siegel BA, Dehdashti F. Lymph node staging by positron emission tomography in patients with carcinoma of the cervix. J Clin Oncol. 2001;19:3745-3749.
9. Grigsby PW, Siegel BA, Dehdashti F, et al. Posttherapy surveillance monitoring of cervical cancer by FDG-PET. IntJ Radiat Oncol Biol Phys. 2003;55:907-913.
10. Rose PG, Adler LP, Rodriguez M, et al. Positron emission tomography for evaluating para-aortic nodal metastasis in locally advanced cervical cancer before surgical staging: a surgicopatho-logic study. JClin Oncol. 1999;17:41-45.
11. Sironi S, Buda A, Picchio M, et al. Lymph node metastasis in patients with clinical early-stage cervical cancer: detection with integrated FDG PET/CT. Radiology. 2006;238:272-279.
12. Cotter SE, Grigsby PW, Siegel BA, et al. FDG-PET/CT in the evaluation of anal carcinoma. Int J Radiat Oncol Biol Phys. 2006;65:720-725.
13. Schwarz JK, Siegel BA, Dehdashti F, et al. Tumor response and survival predicted by post-therapy FDG-PET/CT in anal cancer. Int J Radiat Oncol Biol Phys. 2008;71:180-186.
14. Cohn DE, Dehdashti F, Gibb RK, et al. Prospective evaluation of positron emission tomography for the detection of groin node metastases from vulvar cancer. Gynecol Oncol. 2002;85:179-184.
15. Sohaib SA, Richards PS, Ind T, et al. MR imaging of carcinoma of the vulva. AJR. Am J Roentgenol. 2002;178:373-377.
16. Singh K, Orakwue CO, Honest H, et al. Accuracy of magnetic resonance imaging of inguinofemoral lymph nodes in vulval cancer. Int J Gynecol Cancer. 2006;16:1179-1183.
17. Hacker NF. Surgery for gynaecological cancer: results since the introduction of radical operations. Aust N Z J Obstet Gynaecol. 1990;30:24-28.
18. Homesley HD, Bundy BN, Sedlis A, et al. Assessment of current International Federation of Gynecology and Obstetrics staging of vulvar carcinoma relative to prognostic factors for survival (a Gynecologic Oncology Group study). Am J Obstet Gynecol. 1991;164:997-1003; discussion 1003-1004.
19. Bipat S, Fransen GA, Spijkerboer AM, et al. Is there a role for magnetic resonance imaging in the evaluation of inguinal lymph node metastases in patients with vulva carcinoma? Gynecol Oncol. 2006;103:1001-1006.
20. Oonk MH, Hollema H, de Hullu JA, et al. Prediction of lymph node metastases in vulvar cancer: a review. Int J Gynecol Cancer. 2006;16:963-971.
21. Levenback CF, Ali S, Coleman RL, et al. Lymphatic mapping and sentinel lymph node biopsy in women with squamous cell carcinoma of the vulva: A Gynecologic Oncology Group Study. J Clin Oncol. 2012;30:3786-3791.
22. Van der Zee AG, Oonk MH, De Hullu JA, et al. Sentinel node dissection is safe in the treatment of early-stage vulvar cancer. J Clin Oncol. 2008;26:884-889.
23. Oonk MH, van Hemel BM, Hollema H, et al. Size of sentinel-node metastasis and chances of non-sentinel-node involvement and survival in early stage vulvar cancer: results from GROINSS-V, a multicentre observational study. Lancet Oncol. 2010;11:646-652.
24. Boronow RC. Combined therapy as an alternative to exenteration for locally advanced vulvo-vaginal cancer: rationale and results. Cancer. 1982;49:1085-1091.
25. Boronow RC, Hickman BT, Reagan MT, et al. Combined therapy as an alternative to exenteration for locally advanced vulvovaginal cancer. II. Results, complications, and dosimetric and surgical considerations. Am J Clin Oncol. 1987;10:171-181.
26. Hacker NF, Berek JS, Juillard GJ, et al. Preoperative radiation therapy for locally advanced vulvar cancer. Cancer. 1984;54: 2056-2061.
27. Shimizu Y, Hasumi K, Masubuchi K. Effective chemotherapy consisting of bleomycin, vincristine, mitomycin C, and cisplatin (BOMP) for a patient with inoperable vulvar cancer. Gynecol Oncol. 1990;36:423-427.
28. UK Co-ordinating Committee on Cancer Research, UKCCCR Anal Cancer Trial Working Party. Epidermoid anal cancer: results from the UKCCCR randomised trial of radiotherapy alone versus radiotherapy, 5-fluorouracil, and mitomycin. Lancet. 1996;348: 1049-1054.
29. Ajani JA, Winter KA, Gunderson LL, et al. Fluorouracil, mitomycin, and radiotherapy vs fluorouracil, cisplatin, and radiotherapy for carcinoma of the anal canal: a randomized controlled trial. JAMA. 2008;299:1914-1921.
30. Bartelink H, Roelofsen F, Eschwege F, et al. Concomitant radiotherapy and chemotherapy is superior to radiotherapy alone in the treatment of locally advanced anal cancer: results of a phase III randomized trial of the European Organization for Research and Treatment of Cancer Radiotherapy and Gastrointestinal Cooperative Groups. J Clin Oncol. 1997;15:2040-2049.
31. Flam M, John M, Pajak TF, et al. Role of mitomycin in combination with fluorouracil and radiotherapy, and of salvage chemoradiation in the definitive nonsurgical treatment of epi-dermoid carcinoma of the anal canal: results of a phase III randomized intergroup study. J Clin Oncol. 1996;14:2527-2539.
32. Nigro ND, Vaitkevicius VK, Considine B Jr. Combined therapy for cancer of the anal canal: a preliminary report. Dis Colon Rectum. 1974;17:354-356.
33. Berek JS, Heaps JM, Fu YS, et al. Concurrent cisplatin and 5-fluorouracil chemotherapy and radiation therapy for advanced-stage squamous carcinoma of the vulva. Gynecol Oncol. 1991;42:197-201.
34. Cunningham MJ, Goyer RP, Gibbons SK, et al. Primary radiation, cisplatin, and 5-fluorouracil for advanced squamous carcinoma of the vulva. Gynecol Oncol. 1997;66:258-261.
35. Eifel PJ, Morris M, Burke TW, et al. Prolonged continuous infusion cisplatin and 5-fluorouracil with radiation for locally advanced carcinoma of the vulva. Gynecol Oncol. 1995;59:51-56.
36. Evans LS, Kersh CR, Constable WC, et al. Concomitant 5-fluorouracil, mitomycin-C, and radiotherapy for advanced gynecologic malignancies. Int J Radiat Oncol Biol Phys. 1988;15:901-906.
37. Gerszten K, Selvaraj RN, Kelley J, et al. Preoperative chemo-radiation for locally advanced carcinoma of the vulva. Gynecol Oncol. 2005;99:640-644.
38. Koh WJ, Wallace HJ III, Greer BE, et al. Combined radiotherapy and chemotherapy in the management of local-regionally advanced vulvar cancer. Int J Radiat Oncol Biol Phys. 1993;26:809-816.
39. Landoni F, Maneo A, Zanetta G, et al. Concurrent preoperative chemotherapy with 5-fluorouracil and mitomycin C and radiotherapy (FUMIR) followed by limited surgery in locally advanced and recurrent vulvar carcinoma. Gynecol Oncol. 1996; 61:321-327.
40. Mulayim N, Foster Silver D, Schwartz PE, et al. Chemoradiation with 5-fluorouracil and mitomycin C in the treatment of vulvar squamous cell carcinoma. Gynecol Oncol. 2004;93:659-666.
41. Russell AH, Mesic JB, Scudder SA, et al. Synchronous radiation and cytotoxic chemotherapy for locally advanced or recurrent squamous cancer of the vulva. Gynecol Oncol. 1992;47:14-20.
42. Thomas G, Dembo A, DePetrillo A, et al. Concurrent radiation and chemotherapy in vulvar carcinoma. Gynecol Oncol. 1989;34: 263-267.
43. Wahlen SA, Slater JD, Wagner RJ, et al. Concurrent radiation therapy and chemotherapy in the treatment of primary squamous cell carcinoma of the vulva. Cancer. 1995;75:2289-2294.
44. Gaffney DK, Du Bois A, Narayan K, et al. Patterns of care for radiotherapy in vulvar cancer: a Gynecologic Cancer Intergroup study. Int J Gynecol Cancer. 2009;19:163-167.
45. Moore DH, Thomas GM, Montana GS, et al. Preoperative chemoradiation for advanced vulvar cancer: a phase II study of the Gynecologic Oncology Group. Int J Radiat Oncol Biol Phys. 1998;42:79-85.
46. Montana GS, Thomas GM, Moore DH, et al. Preoperative chemo-radiation for carcinoma of the vulva with N2/N3 nodes: a gynecologic oncology group study. Int J Radiat Oncol Biol Phys. 2000;48:1007-1013.
47. Parsons JT, Bova FJ, Million RR. A re-evaluation of split-course technique for squamous cell carcinoma of the head and neck. Int J Radiat Oncol Biol Phys. 1980;6:1645-1652.
48. Moore DH, Ali S, Koh WJ, et al. A phase II trial of radiation therapy and weekly cisplatin chemotherapy for the treatment of locally-advanced squamous cell carcinoma of the vulva: a gynecologic oncology group study. Gynecol Oncol. 2012;124:529-533.
49. Shylasree TS, Bryant A, Howells RE. Chemoradiation for advanced primary vulval cancer. Cochrane Database Syst Rev. 2011;CD003752.
50. Landrum LM, Skaggs V, Gould N, et al. Comparison of outcome measures in patients with advanced squamous cell carcinoma of the vulva treated with surgery or primary chemoradiation. Gynecol Oncol. 2008;108:584-590.
51. Maneo A, Landoni F, Colombo A, et al. Randomised Study Between Neoadjuvant Chemoradiotherapy and Primary Surgery for the Treatment of Advanced Vulvar Cancer. Int J Gynecol Cancer. 2003;13(suppl 1):6, Abstract PL 19.
52. McCall AR, Olson MC, Potkul RK. The variation of inguinal lymph node depth in adult women and its importance in planning elective irradiation for vulvar cancer. Cancer. 1995;75:2286-2288.
53. Beriwal S, Coon D, Heron DE, et al. Preoperative intensity-modulated radiotherapy and chemotherapy for locally advanced vulvar carcinoma. Gynecol Oncol. 2008;109:291-295.
54. Bloemers MC, Portelance L, Ruo R, et al. A dosimetric evaluation of dose escalation for the radical treatment of locally advanced vulvar cancer by intensity-modulated radiation therapy. Med Dosim. 2012;37:310-313.
55. De Ieso PB, Mullassery V, Shrimali R, et al. Image-guided vulvovaginal interstitial brachytherapy in the treatment of primary and recurrent gynecological malignancies. Brachytherapy. 2012; 11:306-310.
56. Tewari K, Cappuccini F, Syed AM, et al. Interstitial brachytherapy in the treatment of advanced and recurrent vulvar cancer. Am J Obstet Gynecol. 1999;181:91-98.
57. Scheistroen M, Trope C. Combined bleomycin and irradiation in preoperative treatment of advanced squamous cell carcinoma of the vulva. Acta Oncol. 1993;32:657-661.
58. Durrant KR, Mangioni C, Lacave AJ, et al. Bleomycin, methotrexate, and CCNU in advanced inoperable squamous cell carcinoma of the vulva: a phase II study of the EORTC Gynaecological Cancer Cooperative Group (GCCG). Gynecol Oncol. 1990;37:359-362.
59. Wagenaar HC, Colombo N, Vergote I, et al. Bleomycin, methotrexate, and CCNU in locally advanced or recurrent, inoperable, squamous-cell carcinoma of the vulva: an EORTC Gynaecological Cancer Cooperative Group Study. European Organization for Research and Treatment of Cancer. Gynecol Oncol. 2001;81:348-354.
60. Benedetti-Panici P, Greggi S, Scambia G, et al. Cisplatin (P), bleomycin (B), and methotrexate (M) preoperative chemotherapy in locally advanced vulvar carcinoma. Gynecol Oncol. 1993; 50:49-53.
61. Geisler JP, Manahan KJ, Buller RE. Neoadjuvant chemotherapy in vulvar cancer: avoiding primary exenteration. Gynecol Oncol. 2006;100:53-57.
62. Domingues AP, Mota F, Durao M, et al. Neoadjuvant chemotherapy in advanced vulvar cancer. Int J Gynecol Cancer. 2010;20:294-298.
63. Levin W, Goldberg G, Altaras M, et al. The use of concomitant chemotherapy and radiotherapy prior to surgery in advanced stage carcinoma of the vulva. Gynecol Oncol. 1986;25:20-25.
64. Sebag-Montefiore DJ, McLean C, Arnott SJ, et al. Treatment of advanced carcinoma of the vulva with chemoradiotherapy-can exenterative surgery be avoided? Int J Gynecol Cancer. 1994;4:150-155.
65. Lupi G, Raspagliesi F, Zucali R, et al. Combined preoperative chemoradiotherapy followed by radical surgery in locally advanced vulvar carcinoma. A pilot study. Cancer. 1996;77:1472-1478.